We are live on ! Find out more
SYRE icon

Spyre Therapeutics

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$31.6M
BBA
2
Baker Bros. Advisors
New York
$26.8M -$8.04M -38,780 -22%
BlackRock
3
BlackRock
New York
$25.5M +$930K +4,488 +4%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$23.5M
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$23M +$24.2M +116,822 New
BCLSI
6
Bain Capital Life Sciences Investors
Massachusetts
$21.2M
PAMU
7
Pictet Asset Management (UK)
United Kingdom
$19.8M +$11.5M +55,335 +122%
NCM
8
Nantahala Capital Management
Connecticut
$15.5M -$9.53M -45,965 -37%
Vanguard Group
9
Vanguard Group
Pennsylvania
$15.4M +$844K +4,071 +6%
ACM
10
Aisling Capital Management
New York
$13.3M
RSCM
11
Rock Springs Capital Management
Maryland
$12.4M -$87.3K -421 -0.7%
Marshall Wace
12
Marshall Wace
United Kingdom
$9.78M +$6.84K +33 +0.1%
AG
13
Artal Group
Luxembourg
$8.22M
SB
14
Samsara BioCapital
California
$6.96M
SCM
15
Suvretta Capital Management
New York
$5.97M +$1.9M +9,186 +43%
State Street
16
State Street
Massachusetts
$5.72M +$584K +2,819 +11%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$4.46M -$11.8K -57 -0.3%
BC
18
Boxer Capital
California
$4.33M
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$4.25M +$337K +1,624 +8%
Northern Trust
20
Northern Trust
Illinois
$3.78M +$74K +357 +2%
Millennium Management
21
Millennium Management
New York
$3.61M +$3.35M +16,186 +742%
Goldman Sachs
22
Goldman Sachs
New York
$3.42M -$108K -520 -3%
DCM
23
Driehaus Capital Management
Illinois
$3.28M -$48.9K -236 -1%
Axa
24
Axa
France
$3.26M +$903K +4,355 +36%
LPC
25
Lion Point Capital
New York
$2.36M